Test your knowledge of patients who develop polycythemia vera and multiple pulmonary emboli in the setting of uncontrolled disease

According to WHO guidelines, what is the minimum required hematocrit for a diagnosis of polycythemia vera?
50%
48%
45%
60%
Which mutation occurs in ~95% of patients with polycythemia vera?
MPL
FLT3
JAK2
Patients with PV who develop a thrombotic event while on cytoreductive therapy should be considered for an alternative cytoreductive therapy.
True
False
{"name":"Test your knowledge of patients who develop polycythemia vera and multiple pulmonary emboli in the setting of uncontrolled disease", "url":"https://www.quiz-maker.com/Q3X5DTYD8","txt":"According to WHO guidelines, what is the minimum required hematocrit for a diagnosis of polycythemia vera?, Which mutation occurs in ~95% of patients with polycythemia vera?, Patients with PV who develop a thrombotic event while on cytoreductive therapy should be considered for an alternative cytoreductive therapy.","img":"https://www.quiz-maker.com/3012/images/ogquiz.png"}